Links to publications from MedsWatch members, publications from others, and the MedsWatch Dataverse
Substandard and falsified medicines: proposed methods for case finding and sentinel surveillance (Accepted 01/04/21) JMIR Public Health and Surveillance. Accepted preprint. doi: 10.2196/29309
Taking a Cut: Investigating incentives in Indonesia’s medicine supply chain Research report looking at the ways in which supply chain incentives affect medicine price and quality in Indonesia.
Challenges in maintaining medicine quality while aiming for universal health coverage: a qualitative analysis from Indonesia (Published 05 May 2021) BMJ Global Health 2021, 6, e003663
How moves towards universal health coverage could encourage poor quality drugs (https://www.bmj.com/content/366/bmj.l5327) (Published 04 September 2019) BMJ 2019;366:l5327
Identifying market risk for substandard and falsified medicines: an analytic framework based on qualitative research in China, Indonesia, Turkey and Romania (https://wellcomeopenresearch.org/articles/4-70/v1) Pisani E, Nistor AL, Hasnida A et al. Wellcome Open Res 2019, 4:70
Brexit and medicine shortages: evidence from trade data (https://www.bmj.com/content/367/bmj.l5815) (Published 03 October 2019) BMJ 2019;367:l5815
MedsWatch Dataverse: https://dataverse.harvard.edu/dataverse/medswatch